Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Corcoran

Showing results (31-40 of 278) with videos related to

Pageof 28
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Monitoring resistance through liquid biopsyA R Parikh, R B Corcoran
The New England Journal of Medicine|November 1, 2018
Application of Cell-free DNA Analysis to Cancer TreatmentRyan B Corcoran, Bruce A Chabner
Genome Medicine|April 23, 2017
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapyLeanne G Ahronian, Ryan B Corcoran
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2025
Mechanisms of genomic resistance across emerging classes of KRAS inhibitorsJ M Riedl, R B Corcoran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2021
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-ResponseAparna R Parikh, Ryan B Corcoran
Molecular & Cellular Oncology|June 17, 2016
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutationsLeanne G Ahronian, Ryan B Corcoran
Cancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B Corcoran
The New England Journal of Medicine|January 31, 2019
Cell-free DNA Analysis in CancerRyan B Corcoran, Bruce A Chabner
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
DNA as a critical target in toxic cell death: enhancement of dimethylnitrosamine cytotoxicity by DNA repair inhibitorsL M Kamendulis, G B Corcoran
Medicinal Research Reviews|September 17, 2013
Imaging EGFR and HER2 by PET and SPECT: a reviewEmily B Corcoran, Robert N Hanson
Pageof 28

Showing results (31-40 of 278) with videos related to

Sort By:
Pageof 28
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2017
Monitoring resistance through liquid biopsyA R Parikh, R B Corcoran
The New England Journal of Medicine|November 1, 2018
Application of Cell-free DNA Analysis to Cancer TreatmentRyan B Corcoran, Bruce A Chabner
Genome Medicine|April 23, 2017
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapyLeanne G Ahronian, Ryan B Corcoran
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2025
Mechanisms of genomic resistance across emerging classes of KRAS inhibitorsJ M Riedl, R B Corcoran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2021
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-ResponseAparna R Parikh, Ryan B Corcoran
Molecular & Cellular Oncology|June 17, 2016
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutationsLeanne G Ahronian, Ryan B Corcoran
Cancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B Corcoran
The New England Journal of Medicine|January 31, 2019
Cell-free DNA Analysis in CancerRyan B Corcoran, Bruce A Chabner
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
DNA as a critical target in toxic cell death: enhancement of dimethylnitrosamine cytotoxicity by DNA repair inhibitorsL M Kamendulis, G B Corcoran
Medicinal Research Reviews|September 17, 2013
Imaging EGFR and HER2 by PET and SPECT: a reviewEmily B Corcoran, Robert N Hanson
Pageof 28